Intravaginal isonicotinic acid hydrazide (INH) versus misoprostol for cervical ripening prior to hysteroscopy
Authors:
Open Access
- 15 July 2020
- journal article
- research article
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 63 (4) , 514-520
Abstract
The aim of the present study was to compare the efficacy of vaginal isoniazid (isonicotinic acid hydrazide [INH]) and vaginal misoprostol in cervical ripening before hysteroscopic surgery. This randomized controlled trial included patients scheduled for hysteroscopic surgery during April 2016 and June 2017. The inclusion criteria were as follows: postmenopausal women or those at premenopausal age who had not had a vaginal delivery and candidate for diagnostic or operative hysteroscopy with closed cervix before intervention. The INH group (intervention group) received 900 mg of vaginal isoniazid (three 300-mg pills) 6-8 hours before hysteroscopic surgery. The misoprostol group (control group) received 400 micrograms of vaginal misoprostol 6-8 hours before hysteroscopic surgery. Finally, the efficacy of the 2 agents was comparatively analyzed. Baseline characteristics were comparable between the groups. In 67 cases in the INH group (95%) and 45 in the misoprostol group (50%), hysteroscopic entry was successful without additional mechanical dilation, and this difference was statistically significant (P=0.001). The odds ratio (OR) obtained in this study was 0.57 for both INH and misoprostol groups (OR, 0.57; 95% confidence interval, 0.43-0.75). Further, 19 cases in the INH group vs. 45 cases in the misoprostol group did not respond to the intervention, indicating statistically significance (P=0.001). Vaginal INH is more effective than misoprostol in cervical ripening before hysteroscopic surgery and can be a good alternative to misoprostol. Iranian Registry Clinical Trial (IRCT) Identifier: IRCT2015112821506N4.Keywords
This publication has 23 references indexed in Scilit:
- Effectiveness of misoprostol for office hysteroscopy without anesthesia in infertile patientsFertility and Sterility, 2011
- Sublingual misoprostol for cervical ripening before diagnostic hysteroscopy in premenopausal women: A randomized, double blind, placebo-controlled trialFertility and Sterility, 2010
- Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats*Toxicology and Industrial Health, 2008
- Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostolFertility and Sterility, 2008
- Catheter-related infectionsMicrobes and Infection, 2004
- Vaginal misoprostol for cervical priming before operative hysteroscopy: a randomized controlled trialObstetrics & Gynecology, 2000
- Office mini-hysteroscopyHuman Reproduction Update, 1999
- A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortionAmerican Journal of Obstetrics and Gynecology, 1996
- Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestationContraception, 1995
- Comparison of different prostaglandin analogues and laminaria for preoperative dilatation of the cervix in late first trimester abortionContraception, 1983